U.S. flag

An official website of the United States government

NM_003560.4(PLA2G6):c.757G>A (p.Gly253Ser) AND Infantile neuroaxonal dystrophy

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Oct 17, 2022
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000995607.6

Allele description [Variation Report for NM_003560.4(PLA2G6):c.757G>A (p.Gly253Ser)]

NM_003560.4(PLA2G6):c.757G>A (p.Gly253Ser)

Gene:
PLA2G6:phospholipase A2 group VI [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
22q13.1
Genomic location:
Preferred name:
NM_003560.4(PLA2G6):c.757G>A (p.Gly253Ser)
Other names:
NM_003560.4(PLA2G6):c.757G>A; p.Gly253Ser
HGVS:
  • NC_000022.11:g.38140022C>T
  • NG_007094.3:g.79757G>A
  • NM_001004426.3:c.757G>A
  • NM_001199562.3:c.757G>A
  • NM_001349864.2:c.757G>A
  • NM_001349865.2:c.757G>A
  • NM_001349866.2:c.757G>A
  • NM_001349867.2:c.223G>A
  • NM_001349868.2:c.119+3083G>A
  • NM_001349869.2:c.223G>A
  • NM_003560.4:c.757G>AMANE SELECT
  • NP_001004426.1:p.Gly253Ser
  • NP_001186491.1:p.Gly253Ser
  • NP_001336793.1:p.Gly253Ser
  • NP_001336794.1:p.Gly253Ser
  • NP_001336795.1:p.Gly253Ser
  • NP_001336796.1:p.Gly75Ser
  • NP_001336798.1:p.Gly75Ser
  • NP_003551.2:p.Gly253Ser
  • LRG_1015t1:c.757G>A
  • LRG_1015:g.79757G>A
  • LRG_1015p1:p.Gly253Ser
  • NC_000022.10:g.38536029C>T
  • NC_000022.10:g.38536029C>T
  • NG_007094.2:g.70669G>A
Protein change:
G253S
Links:
dbSNP: rs745643715
NCBI 1000 Genomes Browser:
rs745643715
Molecular consequence:
  • NM_001349868.2:c.119+3083G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001004426.3:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001199562.3:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349864.2:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349865.2:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349866.2:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349867.2:c.223G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001349869.2:c.223G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003560.4:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Infantile neuroaxonal dystrophy (NBIA2A)
Synonyms:
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; Seitelberger disease; Infantile neuroaxonal dystrophy 1
Identifiers:
MONDO: MONDO:0024457; MedGen: C0270724; Orphanet: 35069; OMIM: 256600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001149883Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
criteria provided, single submitter

(Classification criteria August 2017)
Likely pathogenic
(May 7, 2019)
germlineclinical testing

Citation Link,

SCV003454502Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 17, 2022)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

Monogenic variants in dystonia: an exome-wide sequencing study.

Zech M, Jech R, Boesch S, Škorvánek M, Weber S, Wagner M, Zhao C, Jochim A, Necpál J, Dincer Y, Vill K, Distelmaier F, Stoklosa M, Krenn M, Grunwald S, Bock-Bierbaum T, Fečíková A, Havránková P, Roth J, Příhodová I, Adamovičová M, Ulmanová O, et al.

Lancet Neurol. 2020 Nov;19(11):908-918. doi: 10.1016/S1474-4422(20)30312-4.

PubMed [citation]
PMID:
33098801
PMCID:
PMC8246240

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München, SCV001149883.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1bloodnot provided1not providednot providednot provided

From Invitae, SCV003454502.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 253 of the PLA2G6 protein (p.Gly253Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of PLA2G6-related conditions (PMID: 33098801). ClinVar contains an entry for this variant (Variation ID: 807465). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PLA2G6 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 26, 2024